The following reflects the views of GMX’s Governance Committee, and is based on the combined research, evaluation, and consensus of various committee members.
Proposal Background
The team have a strong research background, Daniel is a PHD, has experience in upwork user experience insights, studying at Stanford. Savvy Cofounder, Alex is also on the team for the stakeholder management and coordination. Andrea has a good amount of experience in User/UX experiences working for Google, Asana, and Aragon. This collective evidences the potentiality of their deliverables.
It’s very clear this proposal aims to develop insights from existing stakeholders (builders, entrepeneurs, and users) to build an archetype of users who would enable the DAO and foundation to generate insights. The incentive mechanisms can align users to generate positive insights that could be quantifiable and qualitative data translated for the success of Arbitrum.
Comments
Our hesistancy, is mostly leaned on the determination, the how and what information would be collected. Additionally it’s a very broad topic to challenge, usually to solve builder attraction and retention, communication strategies, and other peripheries of this research would require extensive insights, if done right there could be more insights at the forefront.
For this research to be fulfilling on the outset, there needs to be mention of which individuals/groups they’ve outreached (to ensure incentives are not abused), what topics to focus on (narrowing the subject), what the interviewee in the past have they determined in their genuine experience, as some of these questions can be referenced in the forums or information that’s already recognised.
Additionally in typical crypto fashion, many projects are often transparent with what they share on X, forums, or other mediums to showcase their tech stack or progress in Arbitrum.
Overall, we do respect the ambition and intent of the proposal, we generally a see a lack of utilisation and applicability with how it would reflect in Arbitrum.